Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
A new era for ACP
February 4, 2025
New registrar Brad Willsey shares his thoughts about his first few weeks and what lies ahead.
Read more ➞